The US Food and Drug Administration (FDA) has approved Pfizer and BioNTech’s mRNA COVID-19 vaccine, Comirnaty, for people 16 years or older. The announcement represents not just the first approved ...
The Comirnaty 2025-2026 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, a descendant of JN.1. The Food and Drug Administration (FDA) has approved Comirnaty ® (LP.8.1-adapted monovalent ...
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
MedPage Today on MSN
FDA's Vaccine Panel to Weigh XFG Variant for New COVID Shots
But advisors will take a hard look at "Cicada" variant as well ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a change to the license of the Comirnaty Omicron XBB.1.5 30 micrograms/dose (single-dose vials) after it was found to meet ...
Add Yahoo as a preferred source to see more of our stories on Google. COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 ...
LONDON (Reuters) -Pfizer and Moderna's legal battle over their rival COVID-19 vaccines looks set to continue after London's High Court gave a mixed ruling on two of Moderna's patents, likely prompting ...
(RTTNews) - Pfizer Canada ULC and BioNTech SE (BNTX) announced that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for individuals aged 6 months and older. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results